Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00382642Phase 3Completed
Phase 3, randomised, double-blind trial in alcohol dependence comparing Ondansetron with Placebo (2 arms). Primary endpoints: Self-reported measure of alcohol consumption (Drinks per Day), Self-reported measure of alcohol consumption (Drinks per Drinking Day) and 5 more. Started Jun 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00382642.